These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 16200560)

  • 1. Effect of milling and compression on the solid-state Maillard reaction.
    Qiu Z; Stowell JG; Cao W; Morris KR; Byrn SR; Carvajal MT
    J Pharm Sci; 2005 Nov; 94(11):2568-80. PubMed ID: 16200560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of amorphous content on compaction behaviour of anhydrous alpha-lactose.
    Ziffels S; Steckel H
    Int J Pharm; 2010 Mar; 387(1-2):71-8. PubMed ID: 20005927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the re-crystallization behaviour of amorphous lactose using the RH-perfusion cell.
    Timmermann IL; Steckel H; Trunk M
    Eur J Pharm Biopharm; 2006 Aug; 64(1):107-14. PubMed ID: 16527465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetic study of the Maillard reaction between metoclopramide hydrochloride and lactose.
    Qiu Z; Stowell JG; Morris KR; Byrn SR; Pinal R
    Int J Pharm; 2005 Oct; 303(1-2):20-30. PubMed ID: 16126356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Milling induced amorphisation and recrystallization of α-lactose monohydrate.
    Badal Tejedor M; Pazesh S; Nordgren N; Schuleit M; Rutland MW; Alderborn G; Millqvist-Fureby A
    Int J Pharm; 2018 Feb; 537(1-2):140-147. PubMed ID: 29262302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compaction of lactose drug mixtures: quantification of the extent of incompatibility by FT-Raman spectroscopy.
    Flemming A; Picker-Freyer KM
    Eur J Pharm Biopharm; 2008 Mar; 68(3):802-10. PubMed ID: 17826048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moisture sorption, compressibility and caking of lactose polymorphs.
    Listiohadi Y; Hourigan JA; Sleigh RW; Steele RJ
    Int J Pharm; 2008 Jul; 359(1-2):123-34. PubMed ID: 18485633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roller compaction: Effect of morphology and amorphous content of lactose powder on product quality.
    Omar CS; Dhenge RM; Osborne JD; Althaus TO; Palzer S; Hounslow MJ; Salman AD
    Int J Pharm; 2015 Dec; 496(1):63-74. PubMed ID: 26117279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modification of α-lactose monohydrate as a direct compression excipient using roller compaction.
    Abu Fara D; Rashid I; Alkhamis K; Al-Omari M; Chowdhry BZ; Badwan A
    Drug Dev Ind Pharm; 2018 Dec; 44(12):2038-2047. PubMed ID: 30095020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study of the influence of alpha-lactose monohydrate particle morphology on granule and tablet properties after roll compaction/dry granulation.
    Grote S; Kleinebudde P
    Pharm Dev Technol; 2019 Mar; 24(3):314-322. PubMed ID: 29757067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maillard reaction of lactose and fluoxetine hydrochloride, a secondary amine.
    Wirth DD; Baertschi SW; Johnson RA; Maple SR; Miller MS; Hallenbeck DK; Gregg SM
    J Pharm Sci; 1998 Jan; 87(1):31-9. PubMed ID: 9452965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of milling and sieving on functionality of dry powder inhalation products.
    Steckel H; Markefka P; teWierik H; Kammelar R
    Int J Pharm; 2006 Feb; 309(1-2):51-9. PubMed ID: 16377105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of low levels of amorphous content in inhalation grade lactose by moisture sorption isotherms.
    Vollenbroek J; Hebbink GA; Ziffels S; Steckel H
    Int J Pharm; 2010 Aug; 395(1-2):62-70. PubMed ID: 20493937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of spray-dried co-precipitate of amorphous celecoxib containing storage and compression stabilizers.
    Dhumal RS; Shimpi SL; Paradkar AR
    Acta Pharm; 2007 Sep; 57(3):287-300. PubMed ID: 17878109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-milled API-lactose systems for inhalation therapy: impact of magnesium stearate on physico-chemical stability and aerosolization performance.
    Lau M; Young PM; Traini D
    Drug Dev Ind Pharm; 2017 Jun; 43(6):980-988. PubMed ID: 28122460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of crustacean chitin as a co-diluent in direct compression of tablets.
    Mir VG; Heinämäki J; Antikainen O; Sandler N; Revoredo OB; Colarte AI; Nieto OM; Yliruusi J
    AAPS PharmSciTech; 2010 Mar; 11(1):409-15. PubMed ID: 20238188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insensitivity of compaction properties of brittle granules to size enlargement by roller compaction.
    Wu SJ; Sun C
    J Pharm Sci; 2007 May; 96(5):1445-50. PubMed ID: 17455348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of carrier excipient and processing on stability of indorenate hydrochloride/excipient mixtures.
    Villalobos-Hernández JR; Villafuerte-Robles L
    Pharm Dev Technol; 2001 Nov; 6(4):551-61. PubMed ID: 11775956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excipient-free nanoporous microparticles of budesonide for pulmonary delivery.
    Nolan LM; Tajber L; McDonald BF; Barham AS; Corrigan OI; Healy AM
    Eur J Pharm Sci; 2009 Jul; 37(5):593-602. PubMed ID: 19463948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of storage conditions on compaction behavior of two grades of spray-dried lactose.
    Atassi F; Almaya A; Aburub A
    Pharm Dev Technol; 2008; 13(4):277-82. PubMed ID: 18649218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.